Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Dyadic International
AddedFeb 19, 2024
UpdatedJun 18, 2026
Dyadic International

Dyadic International

Public

Dyadic International: A global biotech firm dedicated to advancing drug development for cost-effective, life-saving treatments.

HQ
Jupiter, FL, US
Founded
1979
Overview
Compare
Fundraising
Employees
Website

Dyadic International, Inc. is a global biotechnology company dedicated to advancing drug development through its proprietary C1 expression system. The company aims to help drug developers and manufacturers bring biologic drugs to market more efficiently, focusing on improving access and reducing costs for patients. Dyadic's market focus includes human health, animal health, and cultured meat, all aimed at producing next-generation proteins to enhance global health.

Dyadic has made significant strides in the biotechnology sector, leveraging its innovative microbial platforms to revolutionize biologic vaccine and drug production. The company's impact is evident in its contributions to making life-saving treatments more accessible and affordable. Dyadic's evolution from an industrial textiles company to a leader in life sciences underscores its commitment to scientific advancement and public health.

Dyadic International - Similar Companies

Cydan logo

Cydan

cydanco.com

CytoDyn logo

CytoDyn

cytodyn.com

WuXi Biologics logo

WuXi Biologics

wuxibiologics.com

Intellimedix logo

Intellimedix

Entrada Therapeutics logo

Entrada Therapeutics

entradatx.com

MacroGenics logo

MacroGenics

macrogenics.com

Absci logo

Absci

absci.com

Lumen Bioscience logo

Lumen Bioscience

Kymera Therapeutics logo

Kymera Therapeutics

kymeratx.com

Direct Biologics logo

Direct Biologics

Dyve Biosciences logo

Dyve Biosciences

dyvebio.com

Geneicd logo

Geneicd

Cidara Therapeutics logo

Cidara Therapeutics

cidara.com

Eikon Therapeutics logo

Eikon Therapeutics

eikontx.com

Symic Biomedical logo

Symic Biomedical

Dyadic International - Quick Facts

Who are Dyadic International's competitors?

Companies similar to Dyadic International include Cydan, CytoDyn, WuXi Biologics and Intellimedix.

When was Dyadic International founded?

Dyadic International was founded in 1979.

Where is Dyadic International's headquarters located?

Dyadic International's headquarters is located in Jupiter, FL, US.

How much has Dyadic International raised to-date?

As of Jan 18, 2018, Dyadic International has raised a total of $2M (USD).

How many employees does Dyadic International have?

Dyadic International has 7 employees as of Feb 6, 2024.

Dyadic International - Classification

Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • Global
Model
  • Platform
Revenue
  • Licensing
  • Recurring
Customer
  • Enterprise
  • Government
Main Product
  • Biologics
  • Drug Development
Tags
  • Healthtech
Unique IDs
  • ein: 450486747
  • secCik: 0001213809
  • ticker: DYAI
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 2836Biological Products, Except Diagnostic Substances
  • 2800Chemicals And Allied Products
  • 2830Drugs
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 33 more industry codes
NAICS
  • 320000Manufacturing
  • 325100Basic Chemical Manufacturing
  • 325120Industrial Gas Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325414Biological Product (except Diagnostic) Manufacturing
  • 326000Plastics and Rubber Products Manufacturing
  • 326100Plastics Product Manufacturing
  • 326140Polystyrene Foam Product Manufacturing
  • 326150Urethane and Other Foam Product (except Polystyrene) Manufacturing
  • 541713Research and Development in Nanotechnology
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
  • 541715Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
SIC
  • 2860Industrial Organic Chemicals
  • 2869Industrial Organic Chemicals, Not Elsewhere Classified
  • 3000Rubber And Miscellaneous Plastics Products
  • 3080Miscellaneous Plastics Products
  • 3086Plastics Foam Products
  • 4000Railroad Transportation
  • 6000Depository Institutions
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research
ISIC
  • 2011Manufacture of basic chemicals
  • 2220Manufacture of plastics products
  • 7210Research and experimental development on natural sciences and engineering